{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:44:37Z","timestamp":1787024677089,"version":"build-2736575974"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["DML"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>The liver plays a crucial role in endogenous metabolic activity and homeostasis of\nmacro and micronutrients. Further, it acts as a metabolic hub in mammals, where the ingested\nfood-derived nutrients and xenobiotics or drugs are metabolized for utilization and\/or excretion\nthrough its enzymatic and non-enzymatic machinery. Nutritional deficiency, one of the major\npublic health problems, is associated with global disease burden, including pulmonary tuberculosis\n(PTB) caused by Mycobacterium tuberculosis (Mtb) infection. Though it is a curable and preventable\ninfectious disease, millions of people succumb to death, and people in numbers larger\nthan this are still suffering. This scenario is further complicated by the addition of new cases, disease\nrecurrence, and the emergence of drug-resistant, all of which contribute to the spread of this\nepidemic. Though the manifestation of TB disease has multiple aetiologies, poor nutritional status\nand sub-optimal therapeutic concentrations of first-line anti-TB drugs are considered as potential\ncontributors to its widespread prevalence. Among various factors, the pharmacokinetic variability\nof anti-TB drugs is one of the main causes for sub-optimal therapeutic drug concentration in TB patients,\nwhich is influenced by the host\u2019s genetic make-up and nutritional status, besides several\nothers. However, the role of epigenetic changes in hepatic drug metabolic pathways and their transcript\nlevels is largely unexplored. Therefore, in this review, an attempt has been made to understand\nthe role of micronutrient deficiencies with special reference to fat-soluble vitamins, namely vitamin\nA, D, &amp; E in pulmonary TB, their possible impact on epigenetic changes on the drug-metabolizing\npathway genes, thus their expression levels and plausible influence on pharmacokinetic variability\nof anti-TB drugs, besides discussing the limitations and emerging potential opportunities.\nEventually, this would help in developing the host-directed\/personalized therapeutic strategies for\nthe elimination of pulmonary tuberculosis (PTB).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1872312814999211130093625","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:56:54Z","timestamp":1638316614000},"page":"166-176","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Micronutrient Deficiency in Pulmonary Tuberculosis - Perspective on Hepatic\nDrug Metabolism and Pharmacokinetic Variability of First-line Anti-\nTuberculosis Drugs: Special Reference to Fat-soluble Vitamins A, D, &amp; E\nand Nutri-epigenetics"],"prefix":"10.2174","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-8431","authenticated-orcid":true,"given":"Jeyakumar Shanmugam","family":"Murugaiha","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT), Chennai,\n600031, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Drug Metabolism Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/198412","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/198412\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/198412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T07:45:35Z","timestamp":1640936735000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/198412\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872312814999211130093625","relation":{},"ISSN":["1872-3128"],"issn-type":[{"value":"1872-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}